TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24336419

Group type: EXPERIMENTAL
Intervention: Ocular measures (positive and negative amplitude‐velocity ratio, mean blink duration, percentage of eye closure, composite score of sleepiness levels - Johns Drowsiness Scale)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: aPVT (10‐min auditory psychomotor vigilance task)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic curve analysis of ocular measures
Number of subjects: 10
Study: 22045373

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 18079068

Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Disulfiram-Naltrexone combination
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 17055858

Group type: EXPERIMENTAL
Intervention: Fibrinogen mixture (FM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal saline solution (NS)
Number of subjects: 72
Study: 12743557

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg per day for 16 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 29
Study: 10560780

Group type: EXPERIMENTAL
Intervention: Comprehensive care for hypertensive young urban black men
Number of subjects: 309

Group type: COMPARATOR
Intervention: Men currently using illicit drugs
Number of subjects: 309

Group type: COMPARATOR
Intervention: Men currently taking HBP medication
Number of subjects: 309
Study: 8909273

Group type: EXPERIMENTAL
Intervention: Manual measurement of QRS intervals by experienced clinicians
Number of subjects: 231
Study: 1872159

Group type: EXPERIMENTAL
Intervention: Sutured technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sutureless technique
Number of subjects: 100
Study: 6354234

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 244

Group type: COMPARATOR
Intervention: Emulsified diazepam (diazemuls)
Number of subjects: 244
Study: 29951974

Group type: EXPERIMENTAL
Intervention: Young Adult Family Check-Up (YA-FCU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: School as usual
Number of subjects: 0
Study: 28434694

Group type: EXPERIMENTAL
Intervention: Mini-posterior approach
Number of subjects: 72

Group type: COMPARATOR
Intervention: 2-incision approach
Number of subjects: 72
Study: 26173911

Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter (OFC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Inpatient prostaglandin gel (IPG)
Number of subjects: 101
Study: 23114520

Group type: EXPERIMENTAL
Intervention: HemoCue
Number of subjects: 314

Group type: COMPARATOR
Intervention: Reference method (automated haematology analyser)
Number of subjects: 314
Study: 21945130

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal system (BTDS) 10 or 20 mcg/hour
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal system (BTDS)
Number of subjects: 1024
Study: 18378940

Group type: EXPERIMENTAL
Intervention: Belief-type question
Number of subjects: 45

Group type: COMPARATOR
Intervention: Frequency-type question
Number of subjects: 45

Group type: COMPARATOR
Intervention: Vague question
Number of subjects: 45
Study: 17061223

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (lidocaine 4%)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subconjunctival anesthesia (lidocaine 4%)
Number of subjects: 28
Study: 15599837

Group type: EXPERIMENTAL
Intervention: Patient Support Program (PSP)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 276
Study: 11035828

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (behavior therapy)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nutritional intervention
Number of subjects: 64
Study: 8832318

Group type: EXPERIMENTAL
Intervention: CT scan with quadriceps contracted
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CT scan with quadriceps relaxed
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CT scan in 20 degrees of flexion
Number of subjects: 14
Study: 1521957

Group type: EXPERIMENTAL
Intervention: Group E (n = 11) - nursed and/or collected as much breast milk as possible prior to maximal exercise
Number of subjects: 23

Group type: COMPARATOR
Intervention: Group F (n = 12) - did not nurse or collect milk at least two hours prior to maximal exercise
Number of subjects: 23
Study: 6498565

Group type: EXPERIMENTAL
Intervention: IV lidocaine 1.5 mg X kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ten per cent lidocaine nasal spray (30 mg in each nostril)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No pretreatment (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.25 per cent phenylephrine nasal spray (0.2 mg in each nostril) (Group C)
Number of subjects: 100
Study: 3964592

Group type: EXPERIMENTAL
Intervention: Patients who were interviewed beforehand about their anxiety and expectations of pain (Intervention group).
Number of subjects: 102

Group type: COMPARATOR
Intervention: Patients who were not interviewed beforehand (Control group).
Number of subjects: 102
Study: 31987122

Group type: EXPERIMENTAL
Intervention: 10 capsules/day for four weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: 400 mL/day of a nutritional drink with the same dose of n‐3 LC PUFA
Number of subjects: 41
Study: 29464470

Group type: EXPERIMENTAL
Intervention: Flapless surgical technique (G_B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional technique with mucoperiosteal flap elevation (G_A)
Number of subjects: 30
Study: 27618091

Group type: EXPERIMENTAL
Intervention: Carbohydrate with added protein (CP) during ICT
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Carbohydrate with added protein (CP) during RVT
Number of subjects: 7

Group type: COMPARATOR
Intervention: Carbohydrate (CHO) during ICT
Number of subjects: 7

Group type: COMPARATOR
Intervention: Carbohydrate (CHO) during RVT
Number of subjects: 7
Study: 24344215

Group type: EXPERIMENTAL
Intervention: Standard risk (SR) - two 4-week intensive elements (protocol III)
Number of subjects: 5060

Group type: EXPERIMENTAL
Intervention: Intermediate risk (IR) - protocol III × 3
Number of subjects: 5060

Group type: EXPERIMENTAL
Intervention: High risk (HR) - protocol III × 3
Number of subjects: 5060

Group type: COMPARATOR
Intervention: Control - standard treatment
Number of subjects: 5060
Study: 22531206

Group type: EXPERIMENTAL
Intervention: Remifentanil-atropine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Saline-atropine
Number of subjects: 38
Study: 20695288

Group type: EXPERIMENTAL
Intervention: 20% picaridin spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20% IR3535 spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20% picaridin lotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% IR3535 lotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 33% DEET cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control legs
Number of subjects: 0
Study: 18599286

Group type: EXPERIMENTAL
Intervention: EORTC QLQ‐C30 reporting
Number of subjects: 82
Study: 16733285

Group type: EXPERIMENTAL
Intervention: Water immersion during labour
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Water immersion at 2-cm gaping of the uterine cervix
Number of subjects: 205

Group type: COMPARATOR
Intervention: Traditional delivery (control group)
Number of subjects: 205
Study: 12527978

Group type: EXPERIMENTAL
Intervention: Glucose (GLU)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Trehalose (TRE)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Galactose (GAL)
Number of subjects: 8
Study: 10562791

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms kg‐1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Alfentanil 50 micrograms kg‐1
Number of subjects: 45
Study: 9148172

Group type: EXPERIMENTAL
Intervention: Foreign levodopa preparation combined with carbidopa (25/250)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Polish levodopa preparation combined with carbidopa (25/250)
Number of subjects: 30
Study: 1921737

Group type: EXPERIMENTAL
Intervention: 1 mg 17 beta‐oestradiol (E2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 2.5 mg Org OD 14
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6619028

Group type: EXPERIMENTAL
Intervention: Intravenous azlocillin at 6 g/day in three divided doses
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intravenous ticarcillin at 8 g/day in four divided doses
Number of subjects: 35
Study: 30409669

Group type: EXPERIMENTAL
Intervention: Spanish Diabetes Self‐Management Program (SDSMP)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 297
Study: 30212412

Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 741

Group type: COMPARATOR
Intervention: Colloids
Number of subjects: 741
Study: 27099154

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol-remifentanil (P-R group)
Number of subjects: 50
Study: 25043629

Group type: EXPERIMENTAL
Intervention: Class II compression stockings (Venoflex; Thuasne, Levallois‐Perret, France)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo Jersey
Number of subjects: 126
Study: 22064874

Group type: EXPERIMENTAL
Intervention: Home nursing visits (HNV)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Office-based care (OBC)
Number of subjects: 1154
Study: 20929497

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 51

Group type: COMPARATOR
Intervention: Formula-feeding
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: General infant-feeding options
Number of subjects: 51
Study: 17667476

Group type: EXPERIMENTAL
Intervention: Risperidone (0.5-6.0 mg/day)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Molindone (10-140 mg/day)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 119

Group type: COMPARATOR
Intervention: N/A (control group not specified)
Number of subjects: 119
Study: 16111953

Group type: EXPERIMENTAL
Intervention: Pancreatic stent placement
Number of subjects: 19

Group type: COMPARATOR
Intervention: No pancreatic stent placement (control)
Number of subjects: 19
Study: 11258785

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (P/T) 4.5 g i.v. every 6 hours
Number of subjects: 52

Group type: COMPARATOR
Intervention: Clindamycin (Cl) 900 mg plus aztreonam (Az) 2 g i.v. every 8 hours
Number of subjects: 52
Study: 9230579

Group type: EXPERIMENTAL
Intervention: Serum pepsinogen
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Serum alpha 1‐AT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Blood group O
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mean age
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Early onset of disease
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Gastrointestinal (GI) bleeding
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ulcer perforation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Phenotype analysis of alpha 1‐AT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Genetic anomaly
Number of subjects: 32
Study: 8190879

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Manual toothbrush
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 3555943

Group type: EXPERIMENTAL
Intervention: Ibopamine 300 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Metoclopramide (dopamine antagonist)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Phentolamine (alpha-receptor antagonist) and Propranolol (beta-receptor antagonist)
Number of subjects: 19
Study: 31009707

Group type: EXPERIMENTAL
Intervention: Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) 3.0 g three times daily for 28 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10% XSLJZT comparator
Number of subjects: 80
Study: 28598759

Group type: EXPERIMENTAL
Intervention: Axtair One, an alternating pressure air mattress (APAM)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Viscoelastic foam mattress (VFM)
Number of subjects: 76
Study: 25918964

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 315
Study: 22746262

Group type: EXPERIMENTAL
Intervention: Individualized HIV prevention intervention provided by a medical social worker, including proactive case management for psychosocial problems, counseling about living with HIV, and HIV TRB risk reduction.
Number of subjects: 201

Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 201
Study: 22255047

Group type: COMPARATOR
Intervention: Multivariate matching pursuit algorithm with Gabor atoms and support vector machine with a linear kernel
Number of subjects: 1
Study: 20082244

Group type: EXPERIMENTAL
Intervention: Pulian Ointment (NPLO)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 16696418

Group type: EXPERIMENTAL
Intervention: 5 liters/minute flow of 100% oxygen via tubes attached to the upper chest walls (group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham oxygenation (group 2)
Number of subjects: 80
Study: 15477799

Group type: EXPERIMENTAL
Intervention: Statins (specific dosage and duration not mentioned)
Number of subjects: 0
Study: 11701672

Group type: EXPERIMENTAL
Intervention: Pegvisomant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 0
Study: 9152565

Group type: EXPERIMENTAL
Intervention: 0.5% ketorolac
Number of subjects: 157

Group type: COMPARATOR
Intervention: 1% prednisolone acetate
Number of subjects: 157

Group type: COMPARATOR
Intervention: 0.1% dexamethasone
Number of subjects: 157
Study: 7954250

Group type: EXPERIMENTAL
Intervention: Oral etoposide (60 mg/m2 on Days 1-3 for the first course; 60 mg/m2 on Days 1-4 for the second course; 60 mg/m2 on Days 1-5 for the third course, recycled every 3 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Intravenous vinblastine (3 mg/m2 weekly for 3 weeks, then 6 mg/m2 every 3 weeks)
Number of subjects: 65
Study: 3601828

Group type: EXPERIMENTAL
Intervention: AGM disposable diapers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional disposable diapers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home-laundered cloth diapers
Number of subjects: 0
Study: 29470614

Group type: EXPERIMENTAL
Intervention: Posttherapy PET/CT scans (positive, equivocal, negative)
Number of subjects: 55
Study: 27965864

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) for depersonalisation, delivered over six sessions within a maximum of 10 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 0
Study: 26380438

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment group (needling at Zusanli, Yanglingquan, Neiguan, Guanyuan, once per day for 6 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Thymosin alpha1 group (subdermal injection of thymosin alpha1 1.6 mg, once per day for 6 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (routine treatment according to Surviving Sepsis Campaign guidelines)
Number of subjects: 90
Study: 23782493

Group type: EXPERIMENTAL
Intervention: Salient piece of candy prior to every infusion during three chemotherapy cycles
Number of subjects: 52

Group type: COMPARATOR
Intervention: Flavorless placebo tablets
Number of subjects: 52
Study: 21934637

Group type: EXPERIMENTAL
Intervention: 20 mg vardenafil
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 100 mg sildenafil
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 200 mg udenafil
Number of subjects: 21
Study: 19455176

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched drink (twice a day for 24 weeks)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo drink (twice a day for 24 weeks)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched drink
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 176
Study: 16495423

Group type: EXPERIMENTAL
Intervention: Triage nurse judgment (RN JDGMT)
Number of subjects: 3790

Group type: COMPARATOR
Intervention: Triage prediction rule (PRD)
Number of subjects: 3790

Group type: COMPARATOR
Intervention: EMLA cream (lidocaine 2.5% and prilocaine 2.5%) applied to 'IV likely' patients
Number of subjects: 3790
Study: 15545150

Group type: EXPERIMENTAL
Intervention: Auscultatory sphygmomanometric method with sleeves
Number of subjects: 201

Group type: COMPARATOR
Intervention: Auscultatory sphygmomanometric method without sleeves
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Automatic oscillometric method with sleeves
Number of subjects: 201

Group type: COMPARATOR
Intervention: Automatic oscillometric method without sleeves
Number of subjects: 201
Study: 10868699

Group type: EXPERIMENTAL
Intervention: Serum ferritin concentration >70 microg/liter
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Dietary intake of iron and red meat
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Log ferritin concentration
Number of subjects: 733
Study: 7698064

Group type: EXPERIMENTAL
Intervention: Additional small group education for 2 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual supplementary education for 2 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pharmacist instruction (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 0
Study: 2764526

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 295

Group type: COMPARATOR
Intervention: Amoxicillin with probenecid
Number of subjects: 295
Study: 800381

Group type: EXPERIMENTAL
Intervention: Fenbufen (600-800 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenbufen once a day at bedtime
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenbufen twice a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Indomethacin three times a day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenbufen (both dosing regimens)
Number of subjects: 40
Study: 31311761

Group type: EXPERIMENTAL
Intervention: Bevacizumab + FOLFOX-4 then bevacizumab-5-FU-radiotherapy (RT) before total mesorectal excision (TME) (arm A)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Bevacizumab-5-FU-RT then TME (arm B)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Bevacizumab + FOLFOX-4 then bevacizumab-5-FU-RT (arm A)
Number of subjects: 91
Study: 27327391

Group type: EXPERIMENTAL
Intervention: Modified lap‐tray during sitting and triangular sling while standing
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hemi‐sling while sitting and standing
Number of subjects: 46
Study: 26176592

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted A(H1N1)pdm09 vaccine (1.9 µg HA and AS03B)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted A(H1N1)pdm09 vaccine (3.75 µg HA and AS03A)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted A(H1N1)pdm09 vaccine
Number of subjects: 314
Study: 25098377

Group type: EXPERIMENTAL
Intervention: Intensive vitamin D therapy (alfacalcidiol 0.25 mcg orally with each dialysis session + ergocalciferol 50,000 IU orally once per week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard vitamin D therapy (alfacalcidiol 0.25 mcg orally + placebo each dialysis session)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intensive vitamin D therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard vitamin D therapy
Number of subjects: 60
Study: 22743176

Group type: COMPARATOR
Intervention: PPC heparin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hepalean
Number of subjects: 21
Study: 19056602

Group type: EXPERIMENTAL
Intervention: 5.5-h bedtime condition
Number of subjects: 11

Group type: COMPARATOR
Intervention: 8.5-h bedtime condition
Number of subjects: 11
Study: 17136398

Group type: EXPERIMENTAL
Intervention: 400 mg caffeine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 15784148

Group type: EXPERIMENTAL
Intervention: Sterillium Rub (80% ethanol)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Avagard (61% ethanol and 1% chlorhexidine gluconate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference treatment (n-propanol, 60% v/v)
Number of subjects: 20
Study: 12461496

Group type: EXPERIMENTAL
Intervention: Pediatricians' attitudes toward children's participation in RCTs
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pediatricians' beliefs and relationship with investigators
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pediatricians with previous research experience
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pediatricians' personal treatment preferences
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Education and involvement in trials for pediatricians
Number of subjects: 21
Study: 9806121

Group type: EXPERIMENTAL
Intervention: Sunbathing
Number of subjects: 2615

Group type: EXPERIMENTAL
Intervention: Sunbed use
Number of subjects: 2615

Group type: EXPERIMENTAL
Intervention: Perceived susceptibility to melanoma
Number of subjects: 2615

Group type: EXPERIMENTAL
Intervention: Reasons for sunbathing
Number of subjects: 2615
Study: 8603262

Group type: EXPERIMENTAL
Intervention: Dietary fish oil (MaxEPA 18 g/day) for 10 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unsupplemented group of men with AIDS wasting
Number of subjects: 20
Study: 1759538

Group type: EXPERIMENTAL
Intervention: Interferon 5 x 10(6) units thrice weekly for 4 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Interferon 0.25 x 10(6) U thrice weekly for 6 months (low dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Interferon 3 x 10(6) U thrice weekly for 6 months (high dose)
Number of subjects: 24
Study: 7044649

Group type: EXPERIMENTAL
Intervention: Clonidine (0.2 mg single dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 mg repeated doses bid)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clonidine (1 week treatment)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clonidine (S and R doses) during dynamic physical activity (DPA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clonidine (S and R doses) during DPA
Number of subjects: 6